A Comprehensive Review of COVID-19 Vaccines, Adverse Reactions, and the Imperative of Early Diagnosis
Swetha J., Karthikeyan K., Shanmugasundaram P., Balaji P.
Asian Journal of Case Reports in Medicine and Health · pp. 18–21 · Published 4 Mar 2024
Abstract
Bullous pemphigoid (BP) is a rare autoimmune subepidermal blistering disorder and is defined by the existence of circulating G immunoglobulins (IgG) against basement membrane antigens BP180 and BP230, the immunobullous skin disorder characteristically presents with intense bullae and intense generalized pruritis, where the immune system attacks a thin layer of tissue below the outer layer of skin. Most of the BP cases are due to autoantibodies against proteins arranged at the dermal-epidermal junction, BP is also caused by systemic medications. Either the presence of certain triggering factors in the covid vaccine or the dissimilarity between the vaccine structure and the basement membrane antigens, had activated the B-cell immunity and therefore the production of antibodies, which is the main cause behind the activation of BP. A classic case of this condition is presented here to highlight and to create awareness about the symptoms occurred after COVID-19 vaccination. A 41-year-old female patient presented with BP caused after the administration of 1st dose of covid vaccine.
Cited by 0
No indexed citations yet.
Related research
- Adverse Reaction to Ceftriaxone: How Far Can We Go to exclude an Allergy? — shares topic coverage
- Assessment of Risk for Immune and Psychiatric Disorders Using qPCR-Based Monitoring of the nan Gene in Gut Microbiota: A Non-invasive Approach — shares topic coverage
- Airborne Weed Pollen in Relation to Allergic Rhinitis in Riyadh, Saudi Arabia — shares topic coverage
- Allergy to Argan Oil Confirmed by Oral Challenge Test in Children: Case Report — shares topic coverage
- Far Beyond the IgE: Insights into the Clinical Profile of Allergic Patients with Selective IgE Deficiency, Urticarial Vasculitis, Allergic Pharyngitis, and Perennial Allergic Conjunctivitis — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.